ORAGENICS, INC. Operating Lease Right-of-Use Assets
ORAGENICS, INC. (OGEN) had Operating Lease Right-of-Use Assets of $9.81 thousand as of 2023-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-03-14
- 2023-12-31: Operating Lease, Right-of-Use Asset $9.81K.
- 2023-09-30: Operating Lease, Right-of-Use Asset $24.34K.
- 2023-06-30: Operating Lease, Right-of-Use Asset $249.26K.
- 2023-03-31: Operating Lease, Right-of-Use Asset $298.72K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-12-31 | $9.81K 10-K · filed 2025-03-14 |
| 2023-09-30 | $24.34K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $249.26K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $298.72K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $347.44K 10-K · filed 2024-03-29 |
| 2022-09-30 | $395.44K 10-Q/A · filed 2023-04-14 |
| 2022-06-30 | $385.36K 10-Q/A · filed 2023-04-14 |
| 2022-03-31 | $431.96K 10-Q/A · filed 2023-04-14 |
| 2021-12-31 | $477.88K 10-K · filed 2023-04-17 |
| 2021-09-30 | $523.14K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $567.77K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $611.76K 10-Q · filed 2021-05-03 |
| 2020-12-31 | $655.14K 10-K/A · filed 2022-07-29 |
| 2020-09-30 | $697.91K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $740.09K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $781.67K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $822.68K 10-K · filed 2021-03-01 |
| 2019-09-30 | $714.92K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $756.34K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $132.26K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |